Funding · Growth · 15 September 2026
Magnitude Biosciences raises £1.3m led by Northstar Ventures
Durham-based Magnitude Biosciences has raised £1.3m, led by Northstar Ventures. It builds whole-organism drug screening using imaging, AI and robotics. North East Spinout Inspire Fund, North East Innovation Fund, NPIF II - Maven Equity Finance and others also invested. It plans to expand its VivoScan platform, grow pharma sales and add automation.
0thRound size percentile, 14 growth rounds
Press report
CompanyMagnitude Biosciences
StageGrowth
SectorHealthTech
Based inNorth East
InvestorsNorthstar Ventures, North East Spinout Inspire Fund, North East Innovation Fund, NPIF II - Maven Equity Finance, Finance Durham Fund
SourcePress · confidence highView source ↗
Northstar Ventures's other led rounds
Land Digital · Pre-seed£705kYour note on Magnitude Biosciences
Sign in to keep private notes on this company.
Is this your company?
Hide the valuation estimate straight away, add your investors, or tell us something's wrong. We check every change.